story of the week
Axitinib Plus Pembrolizumab in Advanced RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Axitinib Plus Pembrolizumab in Patients With Advanced Renal-Cell Carcinoma: Long-Term Efficacy and Safety From a Phase Ib Trial
Eur. J. Cancer 2021 Mar 01;145(xx)1-10, MB Atkins, ER Plimack, I Puzanov, MN Fishman, DF McDermott, DC Cho, U Vaishampayan, S George, JC Tarazi, W Duggan, R Perini, M Thakur, KC Fernandez, TK ChoueiriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.